Dr Reddys Laboratories (RDY) Depreciation & Amortization (CF) (2014)
Dr Reddys Laboratories (RDY) recorded quarterly Depreciation & Amortization (CF) of $21.34 in Q1 2014.
Dr Reddys Laboratories (RDY) Depreciation & Amortization (CF) (2014) Analysis & Trends
Dr Reddys Laboratories' Depreciation & Amortization (CF) history runs 1 years deep, the most recent figure standing at $21.34 for Q1 2014.
- In Q1 2014, Depreciation & Amortization (CF) changed N/A year-over-year to $21.34; the TTM figure through Dec 2014 stood at $21.34 (changed N/A YoY), while the FY2026 annual figure was $220.0 million, up 10.0% from the prior year.
- Depreciation & Amortization (CF) was $21.34 for Q1 2014 at Dr Reddys Laboratories.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $21.34 in Q1 2014 to a low of $21.34 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 21.34 |
| Mar 31, 2014 | 21.34 |